Literature DB >> 11800526

Drugs in pregnancy. Pharmacokinetics in pregnancy.

M Dawes1, P J Chowienczyk.   

Abstract

Pharmacokinetics describes the handling of a drug by the body - how the drug is absorbed, distributed and eliminated and how these processes determine plasma concentrations of the drug. Changes in maternal physiology during pregnancy influence pharmacokinetics, and this may have important sequelae for drug dosing, especially for drugs for which adverse effects occur at concentrations within, or just above, the therapeutic range. For many drugs absorption is decreased and elimination increased, thus tending to reduce plasma concentrations. There are, however, relatively few specific data on pharmacokinetics in pregnancy, compared to the non-gravid state, because of the obvious ethical issues surrounding studies during pregnancy. Most therapeutic guidelines are thus based on observational studies and basic principles. Copyright 2001 Harcourt Publishers Ltd.

Mesh:

Substances:

Year:  2001        PMID: 11800526     DOI: 10.1053/beog.2001.0231

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  52 in total

1.  Leveraging physiological data from literature into a pharmacokinetic model to support informative clinical study design in pregnant women.

Authors:  J G Coen van Hasselt; Bruce Green; Glynn A Morrish
Journal:  Pharm Res       Date:  2012-01-13       Impact factor: 4.200

2.  Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.

Authors:  Khaled Abduljalil; Penny Furness; Trevor N Johnson; Amin Rostami-Hodjegan; Hora Soltani
Journal:  Clin Pharmacokinet       Date:  2012-06-01       Impact factor: 6.447

3.  Effects of Pregnancy on the Pharmacokinetics of Metformin.

Authors:  Michael Z Liao; Shannon K Flood Nichols; Mahmoud Ahmed; Shannon Clark; Gary D Hankins; Steve Caritis; Raman Venkataramanan; David Haas; Sara K Quinney; Laura S Haneline; Alan T Tita; Tracy Manuck; Joanne Wang; Kenneth E Thummel; Linda Morris Brown; Zhaoxia Ren; Thomas R Easterling; Mary F Hebert
Journal:  Drug Metab Dispos       Date:  2020-01-24       Impact factor: 3.922

4.  Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial.

Authors:  Yi Zheng; Déborah Hirt; Sandrine Delmas; Gabrielle Lui; Sihem Benaboud; Jerome Lechedanec; Jean-Marc Tréluyer; Camille Chenevier-Gobeaux; Elisa Arezes; Ambre Gelley; Imane Amri; Saïk Urien; Naïm Bouazza; Frantz Foissac; Josiane Warszawski; Jade Ghosn
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

5.  Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention.

Authors:  R Kajubi; L Huang; P Jagannathan; N Chamankhah; M Were; T Ruel; C A Koss; A Kakuru; N Mwebaza; M Kamya; D Havlir; G Dorsey; P J Rosenthal; F T Aweeka
Journal:  Clin Pharmacol Ther       Date:  2017-05-30       Impact factor: 6.875

6.  Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women.

Authors:  P Villani; M Floridia; M F Pirillo; M Cusato; E Tamburrini; A F Cavaliere; G Guaraldi; C Vanzini; A Molinari; A degli Antoni; M Regazzi
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

7.  Pharmacogenetics and other reasons why drugs can fail in pregnancy: higher dose or different drug?

Authors:  David M Haas; Mary DʼAlton
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

8.  Pharmacokinetics of paracetamol and its metabolites in women at delivery and post-partum.

Authors:  Aida Kulo; Mariska Y Peeters; Karel Allegaert; Anne Smits; Jan de Hoon; Rene Verbesselt; Liesbeth Lewi; Marc van de Velde; Catherijne A J Knibbe
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

Review 9.  Oxytocin and postpartum depression: delivering on what's known and what's not.

Authors:  Sohye Kim; Timothy A Soeken; Sara J Cromer; Sheila R Martinez; Leah R Hardy; Lane Strathearn
Journal:  Brain Res       Date:  2013-11-14       Impact factor: 3.252

10.  A randomised controlled trial comparing weight adjusted dose versus fixed dose prophylactic phenylephrine infusion on maintaining systolic blood pressure during caesarean section under spinal anaesthesia.

Authors:  Lucy Mwaura; Vitalis Mung'ayi; Jimmie Kabugi; Samina Mir
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.